Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14062570 | 0.88 | TSHR (0.30) | SMN1; SMN2TSHR | |
| SCHEMBL26948675 | 0.86 | SMN1; SMN2 (0.38) | SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL186352 | 0.85 | SMN1; SMN2 (0.40) | SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL8733901 | 0.83 | TSHR (0.32) | SMN1; SMN2TSHR | |
| SCHEMBL14062566 | 0.82 | TSHR (0.30) | SMN1; SMN2TSHR | |
| SCHEMBL6437353 | 0.81 | TSHR (0.44) | SMN1; SMN2TSHR | |
| SCHEMBL10357220 | 0.79 | TSHR (0.31) | SMN1; SMN2TSHR | |
| SCHEMBL14063423 | 0.79 | TSHR (0.31) | SMN1; SMN2TSHR | |
| SCHEMBL312356 | 0.77 | SMN1; SMN2 (0.36) | SMN1; SMN2TSHRMEN1KMT2A | |
| Perfluorotoluene SCHEMBL308464 | 0.77 | SMN1; SMN2 (0.41) | SMN1; SMN2TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840522-B2 | Method of stabilizing perfluoro(2-methylene-4-methyl-1,3-dioxolane) and composition containing stabilized perfluoro(2-methylene-4-methyl-1,3-dioxolane) | TOSOH CORPORATION (JP) | 2023-12-12 | — | — | US | disclosed |
| US-11840522-B2 | Method of stabilizing perfluoro(2-methylene-4-methyl-1,3-dioxolane) and composition containing stabilized perfluoro(2-methylene-4-methyl-1,3-dioxolane) | TOSOH CORPORATION (JP) | 2023-12-12 | — | — | US | disclosed |
| EP-2555868-B1 | METHOD OF TREATING EFFLUENTS CONTAINING HALOGENATED COMPOUNDS | CENTRE NAT RECH SCIENT (FR) | 2018-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840522-B2 | Method of stabilizing perfluoro(2-methylene-4-methyl-1,3-dioxolane) and composition containing stabilized perfluoro(2-methylene-4-methyl-1,3-dioxolane) | FFAR4, AFF4, PYM1 | SMN1; SMN2 540/4885TSHR 434/4885MEN1 614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.